Knowing that the overexpression of GLUTs is involved in tumor glycolysis - one of the biochemical “hallmarks” of cancer - the efficiency of PcGal16 as an efficient anti-cancer PS is also evidenced by its ability to reduce GLUT1. This evidence concerns the gene SLC2A1 and neoplasm.